How to Help Your Patients Save Money on Vevye: A Provider's Guide to Savings Programs

Author

Peter Daggett

Summarize with AI

Helping Patients Afford Vevye: A Provider's Overview
Program Overview at a Glance
VEVYE Access for All: Recommended First-Line for Most Patients
VEVYE Savings Card: $0 Copay at Retail Pharmacies
Medicare Part D Coverage: 2025 Update
For Uninsured Patients
Transitioning Patients from Compounded Cyclosporine
Counseling Patients at the Point of Prescription
Medfinder: Supporting Patient Access

A guide for ophthalmologists and optometrists on all savings programs available for Vevye, including Access for All, savings cards, Medicare coverage, and Medicaid.

Helping Patients Afford Vevye: A Provider's Overview

Vevye (cyclosporine ophthalmic solution 0.1%) has a retail list price of approximately $900-$1,070 per 2 mL bottle. This cost can immediately derail treatment adherence when patients see it at the pharmacy counter. Fortunately, a well-designed ecosystem of savings programs means most patients can access Vevye for $59 or less in 2026.

Program Overview at a Glance

VEVYE Access for All (PhilRx): $59/bottle, no PA, launched March 2025 — for cash-pay and eligible commercially insured patients
VEVYE Savings Card: $0 copay for eligible commercially insured patients at retail pharmacies
Medicare Part D: Covered by major PBMs (Express Scripts, Cigna, Kaiser, CVS Caremark) as of January 2025
Medicaid: Covered by all U.S. state Medicaid programs
GoodRx and discount cards: Available as a fallback option

VEVYE Access for All: Recommended First-Line for Most Patients

For prescribers, VEVYE Access for All is the most workflow-efficient savings pathway. Launched March 17, 2025 through PhilRx, it was designed to eliminate practice burden from prior authorizations and step therapy edits.

How It Works for Your Practice

Write the Vevye prescription in your EMR as normal
Send electronically to PhilRx (available in most major EMR systems)
PhilRx processes and ships directly to the patient with free home delivery, no PA required
Patient pays $59 (cash-pay) or potentially $0 (eligible commercially insured)

No PA paperwork for your staff. No step therapy requirements. No appeals to manage.

Eligibility Notes

NOT valid for patients with Medicare, Medicaid, Tricare, VA, DOD, or any government-funded program
First fill money-back guarantee available for eligible cash-paying patients
Program questions: call Harrow at 833-442-7769

VEVYE Savings Card: $0 Copay at Retail Pharmacies

For patients who prefer filling at a retail pharmacy with commercial insurance covering Vevye, the VEVYE Savings Card at vevye.com/savings-program can bring copays to as little as $0. Valid at participating retail pharmacies nationwide. Commercially insured patients only — not valid for government insurance programs.

Recommended workflow: Share the URL vevye.com/savings-program with patients at the point of prescription. If PA is required, the card should be registered in advance so it's ready when coverage is approved.

Medicare Part D Coverage: 2025 Update

Effective January 1, 2025, Vevye is covered on key Medicare Part D formularies managed by Express Scripts, Cigna, Kaiser Permanente, and CVS Caremark — representing more than 25 million Medicare Part D beneficiaries. Vevye is also covered by all U.S. Medicaid programs.

The VEVYE Access for All $59 program is NOT available to Medicare beneficiaries. Direct these patients to their Part D plan for formulary tier and copay information. If PA is required, document: DED diagnosis, clinical rationale for Vevye (first cyclosporine for both signs and symptoms, water-free formulation, early onset at 4 weeks), and insufficient response to other measures.

Medicare Extra Help / Low-Income Subsidy (LIS) may significantly reduce costs for low-income beneficiaries. Direct patients to ssa.gov/medicare/part-d to apply.

For Uninsured Patients

VEVYE Access for All at $59 per bottle through PhilRx is the best option for uninsured patients. If $59 is still a barrier: generic cyclosporine 0.05% is approximately $90/month with GoodRx, or Cequa Direct Pricing offers $89/month without insurance.

Transitioning Patients from Compounded Cyclosporine

As of April 2025, VEVYE Access for All has been expanded to facilitate transitions from compounded cyclosporine 0.1% (Klarity-C, ImprimisRx). Prescribers can transfer Klarity-C prescriptions to PhilRx in approximately 5 minutes using a dedicated prescription authorization platform. The $59 pricing applies to these transition patients as well.

Counseling Patients at the Point of Prescription

Tell patients: Vevye can be expensive at retail, but I am sending your prescription to PhilRx where it will cost $59 with free delivery and no insurance hassle
For commercial insurance: register for the VEVYE Savings Card at vevye.com — the copay may be $0
If cost remains an issue: call 833-442-7769 to reach Harrow patient support
Do not stop at the first pharmacy if they quote a price over $1,000 — there are programs that dramatically reduce that price

Medfinder: Supporting Patient Access

Directing patients to Medfinder helps them find Vevye at nearby pharmacies if they prefer local pickup rather than mail order. Medfinder's pharmacy search reduces the frustration of calling multiple pharmacies manually.

Visit Medfinder for Providers to learn more about our platform.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards